| Thrombotic Microangiopathy |
11.0% |
| Therapeutic Response Decreased |
9.9% |
| Pyrexia |
7.7% |
| Sepsis |
7.7% |
| Lymphoproliferative Disorder |
6.6% |
| Thrombocytopenia |
6.6% |
| Epstein-barr Virus Associated Lymphoproliferative Disorder |
5.5% |
| Bronchopulmonary Aspergillosis |
4.4% |
| Cytomegalovirus Infection |
4.4% |
| Renal Infarct |
4.4% |
| White Blood Cell Count Decreased |
4.4% |
| Acute Graft Versus Host Disease |
3.3% |
| Graft Versus Host Disease In Skin |
3.3% |
| Infection |
3.3% |
| Pneumonia Bacterial |
3.3% |
| Rash |
3.3% |
| Renal Failure Acute |
3.3% |
| Vomiting |
3.3% |
| Abdominal Pain Upper |
2.2% |
| Alanine Aminotransferase Increased |
2.2% |
